Skip to main content

Q&A: Investigators Discuss AMR Research at UNC’s Institute for Global Health and Infectious Diseases

May 16, 2024

Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is antimicrobial resistance an important issue? … Read more

Study Finds Increased Risk for Hospital-Acquired Bloodstream Infections Among Racial and Ethnic Minorities

May 16, 2024

A nationwide analysis of a large, geographically diverse cohort of adults in the U.S. suggests there is an increased risk for hospital-acquired carbapenem-resistant enterobacterales (CRE) bloodstream infections among racial and ethnic minorities. Felicia Ruffin, PhD, is a researcher at Duke University School of Medicine in the research group of Vance Fowler, MD, MHS. For this … Read more

Treatment-resistant infections, a “slow-moving catastrophe”

October 11, 2023

From discovery to prevention to treatment, researchers at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections. Nearly every one of us has had an ailment that was treated with an antibiotic. Think about what would happen if that treatment didn’t work. More than 2.8 million antimicrobial-resistant — or treatment-resistant … Read more